Across TCGA pan-cancer cohorts, IGKV1-8 mass-spec protein is linked to patient survival in 1 of 34 cancer types, making it a survival-associated IGKV1-8 data layer compared with 24 for mass-spec protein.
The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher IGKV1-8 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated IGKV1-8 expression acts as an unfavorable survival marker.
CCRCC are the cancer types where IGKV1-8 mass-spec protein most reproducibly stratifies survival.